United States · FDA National Drug Code directory
MESALAMINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62332-724_7d9111a9-c8be-4823-b104-badc44eb08a5
- Product NDC
- 62332-724
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- MESALAMINE
- Labeler
- Alembic Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20221103
- Source listing expiry
- 20261231
Source-listed ingredients
- MESALAMINE — .375 g/1
These values do not establish equivalence or a dose recommendation.
Packages
- 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62332-724-35) · 62332-724-35
- 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62332-724-91) · 62332-724-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →